We'll know more when 2017 closes out and reports. Trial should kick off soon in Boston as well as their progress in Mexico for Proscavax. Getting product launched to cover costs over the next couple quarters should help as well. Of course time will tell as far as market penetration and growth outside of their sales in Mexico.
This is where the risk / reward counts. Not buying what I can't afford to lose, but certainly taking the risk.
News 
Market Data 
Discover 
